Short Interest in CellaVision AB (publ) (OTCMKTS:CLVSF) Decreases By 59.6%

CellaVision AB (publ) (OTCMKTS:CLVSF) was the recipient of a large decline in short interest in the month of January. As of January 30th, there was short interest totaling 2,116 shares, a decline of 59.6% from the January 15th total of 5,239 shares. Based on an average daily trading volume, of 80 shares, the short-interest ratio is currently 26.5 days. Based on an average daily trading volume, of 80 shares, the short-interest ratio is currently 26.5 days.

CellaVision AB (publ) Price Performance

OTCMKTS:CLVSF opened at $15.85 on Friday. The firm has a 50-day moving average of $16.83 and a two-hundred day moving average of $18.09. CellaVision AB has a 1-year low of $16.69 and a 1-year high of $17.30.

About CellaVision AB (publ)

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.